Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Leader in true multi-omic spatial sequencing
Baoyuan Biomedical is a clinical stage company focused on acquiring, developing and commercializing
At Cirina we are pioneering products that detect cancer at its earliest stages and empower you to take action.
Decheng Capital has invested in 51 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Decheng Capital's top investment sectors include Medical, Biotechnology, Health Care, Medical Device, Pharmaceutical. The firm invests across 7 different industry categories.
Among tracked funding rounds, ReadCoor received $27.0M in a Series B round. Decheng Capital's total known invested capital is $3.8B.
Decheng Capital's average investment size is $77.1M across its portfolio of 51 companies.
Recent Decheng Capital portfolio additions include ReadCoor. These companies were founded in 2020 or later.